All Stories

  1. New hematologic populations at risk of invasive aspergillosis: focus on new targeted, biological, and cellular therapies

    Article • F1000Research, July 2019, Faculty of 1000, Ltd.

    Dr Corrado Girmenia

  2. Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

    Article • Infection and Drug Resistance, May 2019, Dove Medical Press

    Dr Corrado Girmenia

  3. Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use

    Article • Journal of Chemotherapy, March 2017, Taylor & Francis

    Medical Doctor Simone Cesaro, Dr Corrado Girmenia, luigina romani

  4. Pulmonary fungal infections in patients with acute myeloid leukaemia: is it the time to revise the radiological diagnostic criteria?

    Article • Mycoses, February 2016, Wiley

    Dr Corrado Girmenia

  5. Prospective Phase II Single-Center Study of the Safety of a Single Very High Dose of Liposomal Amphotericin B for Antifungal Prophylaxis in Patients with Acute Myeloid Leukemia

    Article • Antimicrobial Agents and Chemotherapy, March 2013, ASM Journals

    Dr Corrado Girmenia

  6. A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients

    Article • Hematological Oncology, October 2012, Wiley

    Dr Corrado Girmenia